Drug intelligence / Profile preview

teicoplanin-PMMA

Development stage
Unknown
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Implant
01

Overview

Teicoplanin-PMMA is a combination product consisting of the glycopeptide antibiotic teicoplanin incorporated into poly(methyl methacrylate) (PMMA) bone cement. This formulation is primarily used for local antibiotic delivery in orthopedic procedures, especially for the treatment and prevention of infections associated with prosthetic joints or bone surgeries. Teicoplanin acts by inhibiting peptidoglycan polymerization, thereby blocking bacterial cell wall synthesis and leading to cell death. The incorporation into PMMA allows sustained local release of the antibiotic at the surgical site, providing high concentrations directly where needed while minimizing systemic exposure. Studies have shown that teicoplanin retains its antibacterial activity after being mixed with PMMA and offers prolonged elution compared to other antibiotics like vancomycin or daptomycin when used in this context[2][3][4][9].

Other names
teicoplanin-loaded PMMAteicoplanin-polymethyl methacrylateteicoplanin bone cement
02

Targets

D-Ala-D-Ala (D-Ala-D-Ala terminus)

Beyond the preview

Go deeper on teicoplanin-PMMA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on teicoplanin-PMMA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call